Summit therapeutics plc

Major-Pharmaceuticals

SMMT


136a Eastern Avenue
Abingdon , OX14 4SB

Executive/
Director

Price

  • Last Close
  • $ 7.87
    $ +0.06 0.77 %
    Jun 27, 2024
  • 52-Week High/Low
  • $8.71 - $1.54
  • YTD
  • 201.5%

  • Trading Volume
  • 37,247
  • Market Cap Full
  • $ 5.5B
  • Shares Outstanding
  • 700.8M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -40.7% 55.1% 16.4% 59.1% -5% 24.9% -8.9% -58.8% 58.6%
Q2 -14.8% 18.6% -14.2% -80.6% -36.7% 4% 27.1% -59.2% 43.4% -3.3%
Q3 -1.4% 12% 10.2% -10.5% 17.9% 8% -36.2% 19% -25.5% -
Q4 10.5% -5.5% -11.4% -45.8% -0.7% 38.2% -43.5% 257.1% 47.5% -
J F M A M J J A S O N D
2024 50.2% 15.8% -8.8% -7% - - - - - - - -
2023 -16.5% -49.3% -2.8% -24.6% 23.5% 54% -16.3% -22.9% 15.4% 3.7% 4.6% 28.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-26%29%-90%33%206%-43%58%-39%202%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.55 0.50 -1.1 -0.33 -0.06 -0.21 -0.22 -1.43
Q2 0.45 0.65 0.50 -0.55 -0.2 -0.23 -0.27 -0.17 -0.02
Q3 0.55 0.65 1.10 2.13 -0.2 -0.26 -0.2 -0.14 -0.03
Q4 0.60 0.45 0.20 -0.65 -0.27 - 0.01 0.12 -
A 1.6 2.3 2.3 0.6 -0.9 -0.8 -0.7 -0.4 -1.48

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 160.4 - 82.9 98.1 697.7
Jun - - - 97.2 98.1 697.7
Sep - - - 97.4 98.1 697.7
Dec - 335.9 82.3 97.7 201.3 700.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.5 2 1 1 57
Total Asset Turnover - - - - 0.7
Leverage
Debt Ratio 0.8 - - - -
Debt – Equity Ratio 3.9 - - - -
Interest Coverage -10.3 -28.7 - -13.5 -9
Equity multiplier - - - - -